company background image
SPRINT logo

Sprint Bioscience OM:SPRINT Stock Report

Last Price

SEK 1.34

Market Cap

SEK 93.4m

7D

3.2%

1Y

168.7%

Updated

23 Jul, 2024

Data

Company Financials +

Sprint Bioscience AB (publ)

OM:SPRINT Stock Report

Market Cap: SEK 93.4m

SPRINT Stock Overview

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

SPRINT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Sprint Bioscience AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sprint Bioscience
Historical stock prices
Current Share PriceSEK 1.34
52 Week HighSEK 3.28
52 Week LowSEK 0.45
Beta0.47
11 Month Change-11.04%
3 Month Change-1.62%
1 Year Change168.67%
33 Year Change-76.53%
5 Year Change-91.40%
Change since IPO-91.64%

Recent News & Updates

Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Jun 12
Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Recent updates

Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Jun 12
Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Feb 19
A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

Nov 19
Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

Shareholder Returns

SPRINTSE BiotechsSE Market
7D3.2%5.3%0.2%
1Y168.7%25.7%14.8%

Return vs Industry: SPRINT exceeded the Swedish Biotechs industry which returned 25.7% over the past year.

Return vs Market: SPRINT exceeded the Swedish Market which returned 14.8% over the past year.

Price Volatility

Is SPRINT's price volatile compared to industry and market?
SPRINT volatility
SPRINT Average Weekly Movement8.7%
Biotechs Industry Average Movement8.5%
Market Average Movement5.9%
10% most volatile stocks in SE Market12.5%
10% least volatile stocks in SE Market3.5%

Stable Share Price: SPRINT has not had significant price volatility in the past 3 months.

Volatility Over Time: SPRINT's weekly volatility has decreased from 40% to 9% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200936Johan Emilssonwww.sprintbioscience.com

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. It develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism, nash, and diabetes.

Sprint Bioscience AB (publ) Fundamentals Summary

How do Sprint Bioscience's earnings and revenue compare to its market cap?
SPRINT fundamental statistics
Market capSEK 93.42m
Earnings (TTM)SEK 8.77m
Revenue (TTM)SEK 69.56m

10.6x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SPRINT income statement (TTM)
RevenueSEK 69.56m
Cost of RevenueSEK 13.63m
Gross ProfitSEK 55.93m
Other ExpensesSEK 47.15m
EarningsSEK 8.77m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.13
Gross Margin80.41%
Net Profit Margin12.61%
Debt/Equity Ratio0%

How did SPRINT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.